Acute Graft-vs-host disease (GVHD), a major complication of human bone marrow transplantation, accounts for significant morbidity and mortality in this patient population. Cutaneous GVHD is a manifestation of this condition in a target organ readily accessible for study: the skin. The cellular events and interactions responsible for the initiation and progression of GVHD are not presently understood. The effector cell populations responsible for GVHD involve donor T lymphocytes that potentially initiate a chain of cellular events in the host, culminating in specific target cell injury. Identification of effector mechanisms of GVHD and the donor/host combinations that result in activation of targeting functions have important immuno-therapeutic implications. This present proposal is focused at extending a database indicating that natural killer (NK) cells may be fundamental to lesion formation in GVHD. This study will be facilitated by the availability of a well- characterized murine model of GVHD in which morphologic effects of variations in highly-purified donor T cell inocula and donor/recipient strain combinations can be assessed. Moreover, development of a short-term organ culture system for murine skin will enable characterization of the effects of various putative effector cell populations and recombinant cytokines on target tissue isolated from systemic influences. Importantly, once effector mechanisms have been identified, both in vivo and in vitro, models may be manipulate using specific strategies for enhancement or abrogation of the target cell injury that is ultimately produced. In sum, in situ phenotypic aspects of lesion production and evolution will be determined by the use of both in vivo and in vitro model systems. Ultimate understanding of the nature and complexity of effector/target cell interactions in GVHD depends on the development of experimental models to test morphologic observations already documented in target tissues of man and experimental animals. This study seeks to elucidate the cellular pathology of GVHD in this manner. It is hoped that findings so generated will influence the development of strategies for treatment and prophylaxis of GVHD in humans.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA040358-06
Application #
3180199
Study Section
Pathology B Study Section (PTHB)
Project Start
1987-07-01
Project End
1991-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Ramirez-Montagut, Teresa; Chow, Andrew; Kochman, Adam A et al. (2007) IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease. J Immunol 179:1669-80
DiRienzo, Christine G; Murphy, George F; Friedman, Thea M et al. (2007) T-cell receptor V(alpha) usage by effector CD4+Vbeta11+ T cells mediating graft-versus-host disease directed to minor histocompatibility antigens. Biol Blood Marrow Transplant 13:265-76
Zhan, Qian; Signoretti, Sabina; Whitaker-Menezes, Diana et al. (2007) Cytokeratin15-positive basal epithelial cells targeted in graft-versus-host disease express a constitutive antiapoptotic phenotype. J Invest Dermatol 127:106-15
DiRienzo, Christine G; Murphy, George F; Jones, Stephen C et al. (2006) T-cell receptor Valpha spectratype analysis of a CD4-mediated T-cell response against minor histocompatibility antigens involved in severe graft-versus-host disease. Biol Blood Marrow Transplant 12:818-27
Clark, Rachael A; Chong, Benjamin F; Mirchandani, Nina et al. (2006) A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol 126:1059-70
Durakovic, Nadira; Bezak, Karl B; Skarica, Mario et al. (2006) Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusions. J Immunol 177:4414-25
Sugerman, Philip B; Faber, Sara B; Willis, Lucy M et al. (2004) Kinetics of gene expression in murine cutaneous graft-versus-host disease. Am J Pathol 164:2189-202
Friedman, Thea M; Jones, Stephen C; Statton, Debbie et al. (2004) Evolution of responding CD4+ and CD8+ T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens. Biol Blood Marrow Transplant 10:224-35
Choksi, Swati; Kim, Judith C; Whitaker-Menezes, Diana et al. (2004) A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model. Biol Blood Marrow Transplant 10:669-80
Jones, Stephen C; Friedman, Thea M; Murphy, George F et al. (2004) Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens. Biol Blood Marrow Transplant 10:91-105

Showing the most recent 10 out of 77 publications